Drug Shortage Report for RABAVERT
| Report ID | 231161 |
| Drug Identification Number | 02267667 |
| Brand name | RABAVERT |
| Common or Proper name | rabies virus |
| Company Name | BAVARIAN NORDIC AS |
| Market Status | MARKETED |
| Active Ingredient(s) | INACTIVATED RABIES VIRUS |
| Strength(s) | 2.5UNIT |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 RabAvert vial and 1 Diluent pre-filled syringe |
| ATC code | J07BG |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Delay in shipping of the drug. |
| Anticipated start date | 2024-06-21 |
| Actual start date | 2024-06-21 |
| Estimated end date | 2024-08-15 |
| Actual end date | 2024-08-15 |
| Shortage status | Resolved |
| Updated date | 2024-08-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | PHILIP HEYMANS ALLE 3 HELLERUP, -- DENMARK 2900 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-08-16 | French | Compare |
| v3 | 2024-08-16 | English | Compare |
| v2 | 2024-06-24 | French | Compare |
| v1 | 2024-06-24 | English | Compare |
Showing 1 to 4 of 4